Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to ...

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

Icahn School of Medicine at Mount Sinai is one of more than 800 institutions with graduate schools surveyed by U.S. News on an annual basis. Icahn School of Medicine at Mount Sinai confers degrees ...

Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...

Dr. Jessica Lichter, Assistant Professor and academic hospitalist at Elmhurst Hospital, part of the New York City Health + ...

"Our research reveals the potential for digenic inheritance—where two genes work together to cause disease—expanding our ...

The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed an innovative approach—demonstrated in mouse models and isolated human brain tissue—to safely and effectively deliver ...

announced today that it has entered into a Research Collaboration Agreement with the Icahn School of Medicine at Mount Sinai (“Icahn School of Medicine”) in New York, NY, to explore the ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Do you work at Icahn School of Medicine at Mount Sinai? Manage your school's public image and connection with students using U.S. News Student Connect.

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that ...